Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001193125-26-015486

Director acquired 8,575 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Katkin Keith · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-10 Exercise or conversion : show line 1 in the form +8,575 8,575 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-10 Exercise or conversion : show line 2 in the form Restricted Stock Units −8,575 0 D
Loading xslF345X05/ownership.xml…